Currently out of the existing stock ratings of Naz Rahman, 15 are a BUY (78.95%), 4 are a HOLD (21.05%).

Naz Rahman

Work Performance Price Targets & Ratings Chart

Analyst Naz Rahman works at MAXIM GROUP with a stock forecast success ratio of 41.67% fulfilled within 65.63 days on average.

Naz Rahman’s has documented 33 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PALI, Palisade Bio at 01-May-2024.

Wall Street Analyst Naz Rahman

Analyst best performing recommendations are on VKTX (VIKING THERAPEUTICS).
The best stock recommendation documented was for VKTX (VIKING THERAPEUTICS) at 2/8/2024. The price target of $50 was fulfilled within 19 days with a profit of $21.11 (73.07%) receiving and performance score of 38.46.

Average potential price target upside

CRXT Clarus Therapeutics Holdings PCSA Processa Pharmaceuticals VKTX Viking Therapeutics PALI Palisade Bio QNRX Quoin Pharmaceuticals Ltd DRC SCPH Scpharmaceuticals AGRX Agile Thrpe VRTX Vertex Pharmaceuticals

Analyst name


Current price target

Potential Upside

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score


1 years 9 months 3 days ago

0/1 (0%)

$8.35 (228.77%)



1 years 9 months 4 days ago

0/1 (0%)

$8.7 (202.33%)



2 years 9 days ago

0/1 (0%)

$4.78 (91.57%)



2 years 1 months 15 days ago

0/1 (0%)

$3.91 (48.33%)



2 years 1 months 15 days ago

0/1 (0%)

$11.91 (147.22%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Naz Rahman is most bullish on?

Potential upside of $17.59 has been obtained for PALI (PALISADE BIO)

Which stock is Naz Rahman is most reserved on?

Potential downside of -$12.75 has been obtained for VKTX (VIKING THERAPEUTICS)

What Year was the first public recommendation made by Naz Rahman?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?